UNSPSC 51202204: Sulfasalazine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C18H14N4O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3XC8GUZ6CB, chemically known as salicylic acid, 5-((p-(2-pyridylsulfamoyl)phenyl)azo)- but more generally known as sulfasalazine, which bears US NIH Compound Identifier 5353980. European Medicines Agency schedules Sulfasalazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10727MIG.

UNSPSC 51202204 Sulfasalazine is a Commodity code representing a specific pharmaceutical product, but the recent state and local opportunities posted under this code show little alignment with sulfasalazine procurement itself. The City of Tucson's solicitation for athletic training services and the City of Tampa's solicitation for medical aid supplies (antiseptic sprays, bandages, first aid kits, pain relievers, aspirin) do not reflect demand for sulfasalazine specifically. The Texas Health and Human Services Commission's Request for Information regarding direct-to-manufacturer prescription programs explores pharmacy benefit procurement strategy broadly, not sulfasalazine as a line item. State and local governments appear to buy sulfasalazine through standing pharmaceutical contracts or cooperative purchasing vehicles rather than through dedicated RFPs, RFQs, or ITBs tagged to this code. The code shows minimal targeted recent procurement activity suitable for business development prospecting at the commodity level.

The geographic spread of tagged opportunities spans Arizona, Florida, and Texas, but the mismatch between the code's nominal scope and the actual work being solicited limits the value of this geographic signal. Recent opportunities represent athletic training service contracts (Tucson, due June 9, 2026), general medical supply procurement with small business set-asides (Tampa, ITB 25-P-00157), and exploratory vendor-capability surveys rather than active sulfasalazine demand. Unless a firm is positioned to supply sulfasalazine through state pharmaceutical schedules or cooperative agreements outside formal ITB/RFP channels, this code does not reflect actionable procurement volume in the current cycle.